ScinoPharm Taiwan, Ltd., together with its subsidiaries, researches and develops, produces, and sells cGMP active pharmaceutical ingredients (API) to pharmaceutical companies in Taiwan, the United States, Europe, India, rest of Asia, and internationally. The company offers custom synthesis services for biochemistry molecules, such as peptides and nucleic acids; generic API manufacturing services; and outsourcing services. It also provides CRAM services, such as chemistry skill, analytical and regulatory, chemical process development, clinical drug substance, and consulting services for the development and manufacturing of clinical, small-scale, and commercial-stage APIs and intermediates. In addition, the company develops peptide synthesis technologies. Further, it develops and manufactures western medicines and other chemical materials, albumin medicines, oligonucleotide medicines, injections, and new small molecule drugs, as well as provides biological technology services and technical services. It has a strategic alliance with Baxter International Inc. to develop, manufacture, and commercialize of antiemetic drug in chemotherapy for cancer. ScinoPharm Taiwan, Ltd. was incorporated in 1997 and is headquartered in Tainan City, Taiwan.
ScinoPharm Taiwan Dividend Announcement
• ScinoPharm Taiwan announced a annually dividend of NT$0.30 per ordinary share which will be made payable on 2024-07-26. Ex dividend date: 2024-07-04
• ScinoPharm Taiwan annual dividend for 2024 was NT$0.30
• ScinoPharm Taiwan annual dividend for 2023 was NT$0.36
• ScinoPharm Taiwan's trailing twelve-month (TTM) dividend yield is 1.25%
• ScinoPharm Taiwan's payout ratio for the trailing twelve months (TTM) is 70.64%
• ScinoPharm Taiwan's dividend growth over the last five years (2018-2023) was -5.59% year
• ScinoPharm Taiwan's dividend growth over the last ten years (2013-2023) was -9.59% year
ScinoPharm Taiwan Dividend History
Ex-Div date | Dividend amount | Dividend type | Pay date |
---|---|---|---|
2024-07-04 | NT$0.30 | annually | 2024-07-26 |
2023-07-06 | NT$0.36 | annually | 2023-07-31 |
2022-07-07 | NT$0.48 | annually | 2022-08-02 |
2021-08-26 | NT$0.50 | annually | 2021-09-23 |
2020-07-23 | NT$0.27 | annually | 2020-08-19 |
2019-07-25 | NT$0.49 | annually | 2019-08-20 |
2018-07-26 | NT$0.48 | annually | 2018-08-21 |
2017-08-10 | NT$0.29 | annually | 2017-09-15 |
2016-08-10 | NT$0.27 | annually | |
2015-08-06 | NT$0.18 | annually | |
2014-08-07 | NT$0.99 | annually | |
2013-08-08 | NT$0.99 | annually |
ScinoPharm Taiwan Dividend per year
ScinoPharm Taiwan Dividend growth
ScinoPharm Taiwan Dividend Yield
ScinoPharm Taiwan current trailing twelve-month (TTM) dividend yield is 1.25%. Interested in purchasing ScinoPharm Taiwan stock? Use our calculator to estimate your expected dividend yield:
ScinoPharm Taiwan Financial Ratios
ScinoPharm Taiwan Dividend FAQ
Other factors to consider when evaluating ScinoPharm Taiwan as a dividend stock include its dividend yield, dividend growth, payout ratio, and the sustainability of its dividend payments given its earnings and cash flow. These factors can provide insight into the company's ability to maintain or increase its dividend in the future.
Place an order: Use the brokerage's trading platform to place an order to buy ScinoPharm Taiwan stock.
Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.
1. Determination of Dividend: ScinoPharm Taiwan's board of directors reviews the company's financial performance, cash flow, future investment needs, and other relevant factors to determine the amount and timing of dividend payments.
2. Dividend Declaration: Once the board approves a dividend, ScinoPharm Taiwan publicly announces the dividend amount, currency, and the ex-dividend date. The ex-dividend date is the date on or after which the buyer of the stock will not be eligible to receive the upcoming dividend payment.
3. Record Date: The record date is the date on which the company checks its records to identify shareholders who are eligible to receive the dividend. Only shareholders on record as of this date will receive the dividend.
4. Payment Date: On the designated payment date, ScinoPharm Taiwan distributes the dividend to eligible shareholders. The dividend is usually paid in the form of cash directly into the shareholder's brokerage account or through other designated payment methods.
5. Tax Implications: Dividends received from ScinoPharm Taiwan are generally taxable as income. Shareholders may need to report dividend income on their tax returns and pay applicable taxes according to their jurisdiction's tax regulations.
1. Record Date: ScinoPharm Taiwan sets a record date, which is the date on which the company checks its records to determine the eligible shareholders. Only those who are shareholders on record as of this date will receive the dividend.
2. Payment Date: On the designated payment date, ScinoPharm Taiwan distributes the dividend to eligible shareholders. The payment is usually made electronically, directly into the shareholder's brokerage account or bank account.
3. Currency: ScinoPharm Taiwan declares the currency in which the dividend will be paid. Depending on the shareholder's location and the currency election made by the shareholder, the dividend will be converted to the appropriate currency during the payment process.
To assess the safety of ScinoPharm Taiwan's dividend, it is crucial to analyze the company's financial health, debt levels, cash flow generation, and ability to sustain dividend payments over the long term. Additionally, monitoring the company's future earnings, cash flow projections, and management's commitment to dividend policies can provide valuable insights.
It is recommended to review ScinoPharm Taiwan's financial reports, official announcements, and consult with financial advisors or experts who have access to the most current and comprehensive information about the company's financial situation.